Skip to main content

Infant, Very Low Birth Weight clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for
  • Hydrocortisone for BPD

    Sorry, in progress, not accepting new patients

    The Hydrocortisone and Extubation study will test the safety and efficacy of a 10 day course of hydrocortisone for infants who are less than 30 weeks estimated gestational age and who are intubated at 14-28 days of life. Infants will be randomized to receive hydrocortisone or placebo. This study will determine if hydrocortisone improves infants'survival without moderate or severe BPD and will be associated with improvement in survival without moderate or severe neurodevelopmental impairment at 22 - 26 months corrected age.

    at UCLA

Last updated: